Given that PTPN11 mutations were found in both Noonan syndrome and nonsyndromic patients and that the CHD phenotype was present in all patients, we hypothesize that PTPN11 gene mutations may also be the genetic risk factor for isolated CHD development. Here, PTPN11 is linked to coronary artery disorder.